Table III. Audiological and vestibular test results at baseline and during follow-up.
| # | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| Patient | FC* | FbV† | GC | MR‡ | MG¶ | GS | FS** | GS** | IS** | AC* | FaV† | AMC¶ | MTM* | GS** | RS** | MC¶ | AP | AC | SG | RR‡ |
| Sex | m | m | m | m | m | m | m | m | m | m | m | f | f | f | f | f | f | f | f | f |
| PTA (dBHL) | 12/12 | 12/20 | 20/16 | 38/26 | 12/12 | 31/23 | 51/41 | 31/13 | 10/10 | 26/16 | 12/12 | 20/28 | 17/21 | 10/52 | 23/18 | 13/17 | 24/65 | 24/10 | 10/10 | 11/10 |
| HFPTA (dBHL) | 15/12.5 | 15/30 | 22.5/17.5 | 47.5/20 | 15/12.5 | 45/35 | 70/60 | 37.5/17.5 | 10/10 | 50/25 | 10/10 | 27.5/47.5 | 20/20 | 10/77.5 | 25/22.5 | 17.5/27.5 | 35.5/90 | 47.5/17.5 | 10/10 | 12.5/10 |
| OAEs | N/N | N/N | N/N | A/A | N/N | A/A | A/A | A/A | N/N | A/N | N/N | A/A | A/A | N/A | A/A | N/N | A/A | A/N | N/N | N/N |
| Caloric test | N/N | N/N | W/W | N/N | N/N | A/A | W/W | N/N | N/N | W/N | N/N | N/N | N/N | N/N | N/N | N/N | N/N | N/N | N/N | N/N |
| ABR | N/N | N/N | N/N | C/N | N/N | C/C | C/C | C/N | N/N | C/N | N/N | N/N | N/N | N/C | N/N | N/N | C/C | C/N | N/N | N/N |
| Follow-up (months) | 34 | 29 | 63 | 53 | 46 | 61 | 65 | 69 | 69 | 73 | 37 | 61 | 52 | 70 | 70 | 50 | 25 | 33 | 34 | 36 |
| PTA (dBHL) | 12/12 | 15/14 | 25/20 | 36/16 | 10/10 | 28/30 | 65/70 | 35/20 | 15/20 | 33/20 | 12/12 | 24/25 | 16/16 | 15/60 | 25/20 | 20/15 | 30/65 | 29/17 | 10/10 | 10/10 |
| HFPTA (dBHL) | 22.5/15 | 30/30 | 15/15 | 50/22.5 | 10/10 | 37.5/32.5 | 60/70 | 40/27.5 | 22.5/15 | 52.5/20 | 10/10 | 35/40 | 12.5/22.5 | 10/77.5 | 25/22.5 | 22.5/27.5 | 32.5/90 | 47.5/17.5 | 10/10 | 10/10 |
*, †, ‡, ¶, **: relatives; OAEs (otoacoustic emissions) – A: absent, N: normal; Caloric test – N: normal vestibular responses, W: weakness, A: areflexia; ABR – N: normal, C: cochlear site of lesion.